Currently available non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, diclofenac, indomethacin and flurbiprofen exhibit gastric toxicity. Long-term use of these drugs has been associated with gastro-intestinal (GI) ulceration, bleeding and nephrotoxicity (1). The GI damage from NSAIDs is generally attributed to two factors, local In order to reduce the ulcerogenic effect of ibuprofen, its carboxylic group has been converted into 5-membered heterocyclic rings. Various 1,3,4-oxadiazoles (3-8, 16-21), 1,2,4-triazoles (22-27), 1,3,4-thiadiazoles (28-30), and 1,2,4--triazine (9) derivatives of ibuprofen were prepared by cyclization of 2-(4-i-butylphenyl) propionic acid hydrazide (2) and N 1 -[2-(4-i-butylphenyl)-propionyl]-N 4 -alkyl/aryl--thiosemicarbazides (10-15) under various reaction conditions. The cyclized derivatives were screened for their anti-inflammatory activity by the carrageenan induced rat paw edema method and showed 50 to 86% inhibition, whereas the standard drug ibuprofen showed 92% inhibition at the same oral dose. Five compounds, 7, 16, 18, 22 and 30 that showed more than 80% anti-inflammatory activity were selected to study their analgesic, ulcerogenic and lipid peroxidation activities. All the tested compounds showed a significant reduction in ulcerogenic activity compared to ibuprofen through the severity index 0.5 to 0.8, vs. ibuprofen 1.8. The compounds, that showed less ulcerogenic effect also produced less malondialdehyde content in gastric mucosa, which is one of the end products of lipid peroxidation. The results of biological studies showed that oxadiazole derivative 16 as the lead molecule with maximum anti-inflammatory, analgesic and minimum ulcerogenic and lipid peroxidation activities.
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Keywords: ibuprofen derivatives, anti-inflammatory activity, ulcerogenicity, lipid peroxidation (4) . -To an ethanolic solution of 2 (0.001 mol), cyanogen bromide (0.001 mol) was added. The reaction mixture was stirred with heating at 55-56°C for 2 h. The resulting solution was cooled and neutralized with sodium bicarbonate solution. The solid thus precipitated was filtered, washed with water, dried and recrystallized from methanol. 
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5-[2-(4-i-Butylphenyl)ethyl]-2-(aryl)-1,3,4-oxadiazoles
5-[2-(4-i-Butylphenyl)ethyl]-2-alkyl/aryl-amino-1,3,4-oxadiazoles (16-21
). -A suspension of 10-15 (0.002 mol) in ethanol (50 mL) was dissolved in aqueous sodium hydroxide (5 mol L -1 , 1 mL) under cooling and stirring, resulting in a clear solution. To this, iodine in potassium iodide solution (5%) was added gradually under stirring till the iodine colour persisted at room temperature. The reaction mixture was then refluxed for 4-6 h on a water bath. It was then cooled and poured over crushed ice. The solid mass that was precipitated was filtered, dried and recrystallized from ethanol.
5-[2-(4-i-Butylphenyl)ethyl]-4-alkyl/aryl-3-mercapto-1,2,4(H)-triazoles (22-27
). -A suspension of 10-15 (0.002 mol) in ethanol (25 mL) was dissolved in aqueous sodium hydroxide (4 mol L -1 , 2 mL) and gently refluxed for 6-8 h. The resulting solution was concentrated, cooled and filtered. The filtrate was adjusted to pH 5-6 with diluted acetic acid and was kept aside for 1 h. The crystals produced were filtered, washed with water, dried and recrystallized from ethanol.
5-[2-(4-i-Butylphenyl)ethyl]-2-alkyl/aryl-amino-1,3,4-thiadiazoles (28-30
). -Thiosemicarbazide 10-15 (0.001 mol) was added gradually under stirring to cooled concentrated sulphuric acid (10 mL) for 10 minutes. The reaction mixture was further stirred for another 2-4 h in an ice bath. It was then poured over crushed ice under stirring. The solid precipitated was filtered, washed with water, dried and recrystallized with methanol.
Pharmacology
Wistar rats and albino mice used in the present study were housed and kept in accordance with the Hamdard University Animal Care Unit, which applies the guidelines and rules laid down by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry of Social Justice and Empowerment, Government of India. Wistar rats and albino mice of either sex (Hamdard University, Animal House, New Delhi, India), weighing 180-200 g (12 weeks) and 22-25 g (8 weeks), were used. The animals were housed in groups of six and acclimatized to room conditions for at least 2 days before the experiments. Food and water were freely available up to the time of experiments. The food was withdrawn on the day before the experiment, but free access to water was allowed.
All the compounds (70 mg kg -1 body mass) and the reference NSAID ibuprofen (70 mg kg -1 body mass) were suspended in 1% carboxymethyl cellulose (CMC) and administered orally using an animal feeding needle. The control groups received appropriate volumes of vehicle (1% CMC, oral) only.
Anti-inflammatory activity. -This activity was performed by the following procedure of Winter et al. (13) on groups of six animals each. A freshly prepared suspension of carrageenin (1.0% m/V, 0.1 mL) was injected in the plantar region of the right hind paw of each rat. One group was kept as control and the animals of the other group were pretreated with the test drugs (70 mg kg -1 body mass) suspended in 1.0% CMC given orally 1 h before the carrageenin treatment. The volume was measured before and after 4 h of carrageenin treatment using a pleythysmometer.
Analgesic activity. -Mice were kept individually in the test cage before acetic acid injection and habituated for 30 minutes. Screening of analgesic activity was performed after p.o. administration of test drugs at a dose of 70 mg kg -1 body mass. The compounds, which exhibited good anti-inflammatory activity comparable to that of ibuprofen, were screened for analgesic activity. All compounds were dissolved in 1.0% CMC solution. One group was kept as control and received p.o. 1% CMC. After 1 h of drug administration, 0.10 mL of 1% acetic acid solution was given to mice intraperitoneally. The acetic acid induced writhing test (14) showed stretching movements involving arching of the back, elongation of the body and extension of hind limbs which were counted for 5-15 minutes of acetic acid injection.
Acute ulcerogenesis. -Acute ulcerogenesis test was done according to Cioli et al. (15) . Wistar rats were divided into different groups consisting of six animals each. Ulcerogenic activity was evaluated after p.o. administration of test compounds or ibuprofen at the dose of 200 mg kg -1 body mass. Control rats received p.o. the vehicle (suspension of 1% methylcellulose). Food but not water was removed 24 h before administration of the test compounds. After the drug treatment, the rats were fed normal diet for 17 h and were then sacrificed. The stomach was removed and opened along the greater curvature, washed with distilled water and cleaned gently by dipping in saline. The mucosal damage was examined by means of a magnifying glass. For each stomach the mucosal damage was assessed according to the following scoring system: 0.5 redness; 1.0 spot ulcers; 1.5 hemorrhagic streaks; 2.0 ulcers > 3 but £ 5; 3.0 ulcers > 5.
The mean score of each treated group minus the mean score of control group was regarded as the severity index of gastric mucosal damage.
Lipid peroxidation. -Lipid peroxidation in the gastric mucosa was determined according to the method of Ohkawa et al. (16) . After screening for ulcerogenic activity, the gastric mucosa was scraped with two glass slides, weighed (100 mg) and homogenized in 1.8 mL of 1.15% ice cold KCl solution. The homogenate was supplemented with 0.2 mL of 8.1% sodium dodecyl sulfate (SDS), 1.5 mL of acetate buffer (pH = 3.5) and 1.5 mL of 0.8% thiobarbituric acid (TBA). The mixture was heated at 95°C for 60 minutes. After cooling, the reactants were supplemented with 5 mL of the mixture of n-butanol/pyridine (15:1 V/V), shaken vigorously for 1 minute and centrifuged for 10 minutes at 4000 rpm. The supernatant organic layer was taken out and absorbance was measured at 532 nm on a UV spectrophotometer. The results were expressed as nmol malondialdehyde (MDA) per 100 mg tissue, using a molar absorption coefficient of 1.56 × 10 5 cm -1 mol -1 (17) .
All the pharmacological data are expressed as mean ± SEM; Student's t-test was applied to determine the significance of the difference between the control group and groups of animals treated with the test compounds.
RESULTS AND DISCUSSION
The acid hydrazide 2 was prepared by esterification of 2-(4-i-butylphenyl) propionic acid followed by treatment with hydrazine hydrate in absolute ethanol. The reaction of hydrazide 2 with carbon disulphide in alkaline medium afforded, after acidic treatment, 5-[2-(4-i-butylphenyl)ethyl]-2-mercapto-1,3,4-oxadiazole (3). The IR spectrum of compound 3 revealed the presence of absorption bands at 1140 cm -1 for C=S group and at 1652 cm -1 due to C=N stretching vibrations. Also, the 1 H NMR spectrum of 3 showed a singlet at d 10.53 ppm for the SH proton, confirming the formation of a mercapto triazole ring. The mass spectra showed the molecular ion peak M + at m/z 262 corresponding to the molecular formula C 14 H 18 N 2 OS. Treatment of hydrazide with cyanogen bromide afforded 5-[2-(4-i-butylphenyl)ethyl]-2-amino-1,3,4-oxadiazole (4). The IR spectrum of compound 4 showed absorption peaks at 1640 cm -1 due to C=N stretching vibrations. Also, the 1 H NMR spectrum of compounds is in agreement with its structure, which revealed a singlet at d 6.17 due to the NH 2 proton attached to the 2 nd position of oxadiazole ring. The mass spectra showed the molecular ion peak M + at m/z 245 corresponding to the molecular formula C 14 H 19 N 3 O. Various 2-aryl-1,3,4-oxadiazoles 5-8 were prepared by treatment of hydrazide with appropriate aromatic acids in the presence of phosphorus oxychloride. The structure of oxadiazole 8 was established by its IR spectrum, which showed an absorption peak at 1645 cm -1 due to C=N stretching vibrations. The compound 1 H NMR spectra displayed a singlet at d 6.59 attributed to NH 2 protons and a multiplet at d 7.33-7.68 for 8 ArH protons. The mass spectra showed the molecular ion peak M + at m/z 321 corresponding to the molecular formula C 20 H 23 N 3 O. 3-[2-(4-i-Butylphenyl)ethyl]--1,2,5,6-tetrahydro-1,2,4-triazine-5-one (9) was prepared by condensation of hydrazide with chloroacetamide. The structure of compound was confirmed by appearance of absorption peaks at 1588 cm -1 due to C=N and 1648 cm -1 corresponding to C=O group. The 1 H NMR spectrum of compounds showed a singlet at d 2.43 ppm for CH 2 proton of triazinone ring. The presence of two broad singlets at d 5.38 and 6.07 ppm for NH protons also confirms the formation of the compound. The mass spectra of compound 9 showed molecular ion peak M + at m/z 259 corresponding to molecular formula C 15 H 21 N 3 O.
Furthermore, hydrazide 2 on treatment with various alkyl/aryl i-thiocyanates gave (10) (11) (12) (13) (14) (15) . The structure of thiosemicarbazide 10 was confirmed by its IR spectrum, which displayed absorption bands at 3337 cm -1 for NH, 1665 cm -1 due to C=O and 1160 cm -1 corresponding to C=S stretch vibrations. The 1 H NMR spectrum showed a multiplet at d 7.11-7.26 ppm for 4 ArH protons. The CSNH and CONH protons were observed as a singlet at d 8.62 and 9.04 ppm, respectively, confirming the formation of thiosemicarbazide. The mass spectra showed molecular ion peak M + at m/z 335 corresponding to molecular formula C 18 H 29 N 3 OS.
The thiosemicarbazides were oxidatively cyclised to 2-alkyl/arylamino-5-substituted-1,3,4-oxadiazoles (16-21) by elimination of H 2 S using iodine and potassium iodide in ethanolic sodium hydroxide. The IR spectrum of oxadiazole 16 showed absorption peak at 1560 cm -1 due to C=N stretch vibration. The structure was further supported by its 1 H NMR spectrum, which showed a multiplet at d 6.91-7.15 ppm for 4 ArH and 1 NH protons. The mass spectra showed molecular ion peak M + at m/z 301 corresponding to molecular formula C 18 H 27 N 3 O. The thiosemicarbazides 10-15 on heating with 4 mol L -1 NaOH in ethanol underwent smooth cyclisation through dehydration to afford 5-substituted-4-alkyl/aryl-3-mercapto-4H-1,2,4-triazoles (22-27). The structure of triazole 22 was confirmed by its IR spectrum, which displayed absorption peak at 1560 cm -1 due to C=N and at 1080 cm -1 corresponding to C=S group. The formation of triazole ring was further supported by its 1 H NMR spectrum, which showed a triplet for NCH 2 proton at d 3.56 ppm. A singlet for SH proton was also observed at d 11.10 ppm. The mass spectra of the compound 22 showed molecular ion peak M + at m/z 317 corresponding to molecular formula C 18 H 27 N 3 S. 2-Alkyl/arylamino-5-substituted-1,3,4-thiadiazoles (28-30) were obtained by cyclisation of 10-15 by treating with cold concentrated sulphuric acid. The IR spectrum of compound 30 showed absorption peak at 1620 cm -1 due to C=N stretching vibration. In the 1 H NMR spectrum of the compound the singlet of CSNH and CONH of thiosemicarbazide disappeared and a multiplet was obtained in the aromatic region at d 7.26-7.69 ppm for 8 ArH protons. The NH proton was observed as a singlet at d 8.17 confirming he structure of compound. The mass spectra of the compound 30 showed molecular ion peak M + at m/z 371 corresponding to molecular formula C 20 H 22 ClN 3 S.
The anti-inflammatory activity of the synthesized compounds 3, 4, 7, 9, 16-19, 21-24, 27-30 were evaluated by the carrageenin induced paw edema method. The compounds were tested at an oral dose of 70 mg kg -1 body mass and were compared with the standard drug ibuprofen at the same oral dose. The tested compounds showed anti-inflammatory activity ranging from 50 to 86% (Table II) , and the standard drug ibuprofen showed 92% inhibition after 4 hours. The oxadiazole derivative 16 having an n-butyl amino group showed the maximum activity (86%), whereas when this group was replaced by the cyclohexyl amino group 17 the activity was found to be minimal (50%). It was observed that oxadiazole derivatives having p-chlorophenyl amino, o-methoxyphenyl amino and 2,4-dichloromethoxyphenyl groups at the 2 nd position showed high activity (85, 79 and 82%), respectively. When these groups were replaced by p-fluorophenyl amino (19), 2-mercapto (3) and 2-amino (4) groups, the activity was found to be reduced. The 1,2,4-triazole derivatives of ibuprofen showed anti-inflammatory activity ranging from 68 to 82%. The highest activity was found for the triazole derivatives 22 and 27 (82%), having the n-butyl group and o-methoxyphenyl group at position 4. When these groups were replaced by the cyclohexyl group in compound 23, the activity was found to be minimal (68%). The triazole derivative 24 having the p-chlorophenyl group showed moderate activity.
The 1,3,4-thiadiazole derivatives of ibuprofen showed anti-inflammatory activity ranging from 75 to 84%. Maximum activity was shown by the thiadiazole derivative 30 having the p-chlorophenyl amino group at position 2. When this group was replaced by the n-butyl amino group in derivative 28, the activity was found to be decreased (75%), whereas in case of oxadiazole and triazole derivatives the compound having the n-butyl group showed highest activity. When the hydrazide of ibuprofen was treated with 2-chloroacetamide, 1,2,4-triazine derivative was obtained, which also showed significant anti-inflammatory activity (71%).
The compounds that showed anti-inflammatory activity higher than 80% were tested for analgesic activity. Compounds 7, 16, 18, 22 and 30 showed analgesic activity ranging from 57 to 73%, whereas the standard drug ibuprofen showed 84% at a 70 mg kg -1 oral dose. Among all the tested compounds, the oxadiazole derivative having the n-butyl amino group 16 showed maximum activity (73%). When this group was replaced by the p-chlorophenyl amino (18) and 2,4-dichloromethoxyphenyl group (7), there was a significant decrease in the activity. Among all the tested compounds, thiadiazole 30 showed minimum activity (57%), whereas triazole derivative 22 showed significant analgesic activity (71%). 
